Search
for
Sort by
Research 421–450 of 1000+
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Androgenetic Alopecia is Associated With Increased Risk of Peripheral Venous Disorders in a Large Retrospective Cohort Study
- Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Management of congenital ichthyoses: European guidelines of care, part two
- The role of androgens in hormone replacement therapy
- Androgenetic alopecia and risk of coronary artery disease
- Assessment of cardiovascular risk in patients with androgenetic alopecia using high-sensitivity C-reactive protein and lipoprotein a
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Unhealthy lifestyle and the risk of metabolic syndrome - the Romanian experience
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse
- Efficient Gene Editing for Heart Disease via ELIP-Based CRISPR Delivery System
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Business Continuity and Risk Mitigation in the Pharmaceutical Industry: Strengthening Supply Chains for Pandemic Preparedness
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Immunogenetic and metabolic risk factors in male androgenetic alopecia: the role of HLA-DRB1 alleles and vitamin D3 deficiency